Primary immunodeficiencies are notoriously difficult to identify because their wide-ranging symptoms can seem unrelated. This ...

The prevalence of gene variants linked to cardiomyopathy is markedly higher in patients with AF, and particularly those with ...

Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...

Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining ...

A Brisbane nurse has been diagnosed with a brain tumour which she believes could’ve been discovered years earlier with ...

“Prioritizing Counseling in Genetic Counseling” was a thought-provoking workshop title at the 2025 European Society of Human ...

Knoxville Comprehensive Breast Center and the Dermatopathology Laboratory settled with the federal government.

A rare genetic mutation in a European sperm donor has reportedly caused cancer in 10 children, highlighting the need for ...

An online platform may help increase access to and reduce barriers associated with germline testing for individuals with cancer, according to findings presented at ASCO Annual Meeting.An analysis of ...

Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform ...

Historically, professional society guidelines have recommended limited genetic testing for hereditary cancer syndromes (HCS) to patients with cancer thought to be at highest risk for carrying ...

(Reuters) -Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.